Case Report Shows Sudden Vision Loss in Healthy Adult Using GLP-1 Drugs A detailed case report published in the International Medical Case Reports Journal described the vision loss of a 47-year-old woman after using two GLP-1 drugs liraglutide and later semaglutide
Animals are recovered with initiation of a multimodal analgesic protocol supplemented as needed to prevent distress (fentanyl patch and buprenorphine, 4 g/kg and 0.03 mg/kg, respectively)
People following GLP-1based weight-management programs may be using different medications, including commonly known options such as Ozempic, Wegovy, Zepbound, or Mounjaro
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
If approved, a type of group lawsuit called a multicounty litigation (MCL) will be created
Primes GLP-1 Pipeline Update provides a credible clinical snapshot of what is on the horizon